Talla final en varones sintomáticos con hiperplasia suprarrenal no clásica tratados con glucocorticoides: Casos clínicos

Pasqualini, Titania; Alonso, Guillermo; Fernández, Cecilia; Buzzalino, Noemí; Dain, Liliana.
Arch. argent. pediatr ; 111(2): 0-0, Apr. 2013. ilus
Artículo en Español | LILACS | ID: lil-672000

Documentos relacionados

  1. Talla final en varones sintomáticos con hiperplasia suprarrenal no clásica tratados con glucocorticoides: Casos clínicos
  2. [Steroid 21-hydroxylase deficiency, the most frequent cause of congenital adrenal hyperplasia].
  3. Congenital adrenal hyperplasia.
  4. [Final height in symptomatic boys with late-onset adrenal hyperplasia (LOCAH), treated with glucocorticoids. Clinical cases].
  5. [Long-term morbidity in congenital adrenal hyperplasia].
  6. Novel treatments for congenital adrenal hyperplasia.
  7. Endocrine, cardiac and neuropsychological aspects of adult congenital adrenal hyperplasia.
  8. Current Advances in the Management of Congenital Adrenal Hyperplasia.
  9. The management of congenital adrenal hyperplasia during preconception, pregnancy, and postpartum.
  10. Do All Patients with Congenital Adrenal Hyperplasia Need to Be on Hydrocortisone Three Times a Day in Order to Have Normal Growth?